Japan’s $2-Billion Initiative to Prep Pandemic Vaccines in 100 Days

September 23, 2022

(Nature) – After recognizing that Japan was slow to develop vaccines for COVID-19, the government has pledged to invest US$2 billion in a vaccine-research initiative to ensure that the country is ready to respond promptly to future epidemics. The Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) will initially invest in vaccine research for eight pathogens, including coronaviruses, monkeypox, dengue virus and Zika virus, using a range of technologies for vaccine delivery, such as mRNA technology, viral vectors and recombinant proteins. (Read More)